The Latest Breaking News from Weill Cornell Medicine

Data from a landmark international trial show half of patients with metastatic melanoma treated with a immune checkpoint people live cancer-free for 10 years or more. Read further on Dynamite News:

Research suggests expanded frontostriatal salience network could be risk factor for developing condition

A preclinical study conducted by Weill Cornell Medicine researchers reveals that a certain human genetic variant of a receptor that increases insulin release may help individuals be more resistant to obesity. Read further on Dynamite News:

St. John’s Research Institute (SJRI) in Bengaluru is one of the four international sites that will actively collaborate with Cornell University in the USA for development, deployment, clinical validation, and commercialisation of point-of-care (POC) diagnostic devices and technologies. 

According to a study conducted by scientists at Weill Cornell Medicine, the vertebral bones that make up the spine originate from a special kind of stem cell that secretes a protein that encourages tumour metastasis. Read further on Dynamite News:

A potential strategy for treating diabetes uses stem cells from the human stomach to create cells that release insulin in response to rising blood sugar levels. Read further on Dynamite News:

The team at Weill Cornell Medicine hailed the breakthrough contraceptive pills for men that can be taken just before sex.

Bryce Demopoulos was on his way to Weill Cornell Medicine when the heroic deed took place at the Third Avenue-138 Street station